BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 17547114)

  • 1. [Treatment of arterial hypertension with the use of trandolapril for patients with metabolic syndrome].
    Samsonova NG; Mikheeva OM; Nilova TV
    Eksp Klin Gastroenterol; 2007; (1):51-4. PubMed ID: 17547114
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of a fixed-dose combination of trandolapril-verapamil in obese hypertensive patients resistant to monotherapy.
    Rubio-Guerra AF; Lozano-Nuevo JJ; Vargas-Ayala G; Rodríguez-López L; Ramos-Brizuela LM; Escalante-Acosta BA
    Clin Exp Hypertens; 2006 Oct; 28(7):619-24. PubMed ID: 17060060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic and clinical outcomes in nondiabetic individuals with the metabolic syndrome assigned to chlorthalidone, amlodipine, or lisinopril as initial treatment for hypertension: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Black HR; Davis B; Barzilay J; Nwachuku C; Baimbridge C; Marginean H; Wright JT; Basile J; Wong ND; Whelton P; Dart RA; Thadani U;
    Diabetes Care; 2008 Feb; 31(2):353-60. PubMed ID: 18000186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical evaluation of SE 1520 in the treatment of hypertension.
    Seedat YK; Reddy J
    Curr Ther Res Clin Exp; 1974 Apr; 16(4):275-80. PubMed ID: 4208341
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experiments with dimecarbine treatment of patients with hypertensive disease].
    Egorov MN; Vasil'ev LI; Mishchenko ED
    Klin Med (Mosk); 1966 May; 44(5):62-5. PubMed ID: 5990931
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of hypertension and other cardiovascular risk factors in patients with metabolic syndrome.
    Suzuki T; Homma S
    Med Clin North Am; 2007 Nov; 91(6):1211-23, x. PubMed ID: 17964917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The choice of antihypertensive therapy in patients with the metabolic syndrome--time to change recommendations?
    Hilgers KF; Mann JF
    Nephrol Dial Transplant; 2008 Nov; 23(11):3389-91. PubMed ID: 18687734
    [No Abstract]   [Full Text] [Related]  

  • 8. Increased prevalence of metabolic syndrome in uncontrolled hypertension across Europe: the Global Cardiometabolic Risk Profile in Patients with hypertension disease survey.
    Kjeldsen SE; Naditch-Brule L; Perlini S; Zidek W; Farsang C
    J Hypertens; 2008 Oct; 26(10):2064-70. PubMed ID: 18806632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Results of gopten monotherapy in drivers having arterial hypertension].
    Aramisova RM; Elgarov AA
    Med Tr Prom Ekol; 2002; (4):32-4. PubMed ID: 12061073
    [No Abstract]   [Full Text] [Related]  

  • 10. [Principle for treatment of hypertension].
    Ogihara T
    Nihon Rinsho; 2011 Jan; 69 Suppl 1():571-5. PubMed ID: 21766662
    [No Abstract]   [Full Text] [Related]  

  • 11. Manidipine in hypertensive patients with metabolic syndrome: the MARIMBA study.
    Martínez Martín FJ
    Expert Rev Cardiovasc Ther; 2009 Jul; 7(7):863-9. PubMed ID: 19589122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of hypertension in patients with diabetes mellitus and metabolic syndrome in Swiss primary care.
    Schäfer HH; de Villiers JD; Sudano I; Theus GR; Sivukhina E; Burnier M; Dieterle T; Noll G
    Int J Clin Pract; 2012 Nov; 66(11):1125-6. PubMed ID: 23067037
    [No Abstract]   [Full Text] [Related]  

  • 13. Indoramin in the treatment of hypertension.
    Stannard M; Cohen M
    Practitioner; 1983 Oct; 227(1384):1601-5. PubMed ID: 6634630
    [No Abstract]   [Full Text] [Related]  

  • 14. [High blood pressure discovered by a causal measurement. Problems concerning diagnosis of hypertension and selection of antihypertensive treatment].
    Hansen OP; Hansen M; Lindholm J
    Ugeskr Laeger; 1978 Nov; 140(47):2923-6. PubMed ID: 715906
    [No Abstract]   [Full Text] [Related]  

  • 15. The metabolic syndrome in hypertension: European society of hypertension position statement.
    Redon J; Cifkova R; Laurent S; Nilsson P; Narkiewicz K; Erdine S; Mancia G;
    J Hypertens; 2008 Oct; 26(10):1891-900. PubMed ID: 18806611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hypotensive and metabolic effect of indapamide and perindopril in patients with type 2 diabetes and arterial hypertensia].
    Askerov MM
    Georgian Med News; 2009 Apr; (169):44-8. PubMed ID: 19430043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical evaluation of indoramin as the sole agent for the treatment of hypertension.
    Kramer R; Rosendorff C; Bloom D
    S Afr Med J; 1974 Aug; 48(37):1569-72. PubMed ID: 4851044
    [No Abstract]   [Full Text] [Related]  

  • 18. [Arterial hypertension in the child. Some new aspects. Symptomatic treatment].
    Regy JM; Fauchier C; Morand P
    Ann Cardiol Angeiol (Paris); 1970; 19(3):229-38. PubMed ID: 5454971
    [No Abstract]   [Full Text] [Related]  

  • 19. Trandolapril / verapamil SR combination reverses drug-induced new-onset diabetes.
    Cardiovasc J Afr; 2008; 19(2):118. PubMed ID: 18516363
    [No Abstract]   [Full Text] [Related]  

  • 20. [Normalization of arterial pressure in all hypertensive patients: mission impossible?].
    Waeber B
    Schweiz Med Wochenschr; 1998 Jan; 128(1-2):42-4. PubMed ID: 9491471
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.